Chargement en cours...
Intravenous vortioxetine to accelerate onset of effect in major depressive disorder: a 2-week, randomized, double-blind, placebo-controlled study
This 2-week randomized, double-blind, placebo-controlled fixed-dose study (NCT02919501) explored the potential of accelerating onset of antidepressant efficacy and plasma exposure with single-dose intravenous vortioxetine at oral vortioxetine treatment initiation. Outpatients (ages 18–65 years) with...
Enregistré dans:
| Publié dans: | Int Clin Psychopharmacol |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Lippincott Williams And Wilkins
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6587371/ https://ncbi.nlm.nih.gov/pubmed/31094901 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/YIC.0000000000000271 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|